Skip to main content
TipRanks
Go Ultimate75% OFF

Markus Renschler Insider Profile

4 Followers

Markus Renschler, former Sr. VP, Oncology Clinical Dev at Pharmacyclics, holds 1.39K shares in Pharmacyclics (Ticker: PCYC), holds 1.10M shares in Cyteir Therapeutics (Ticker: CYT).

Markus Renschler's Trading History

CYT
Cyteir Therapeutics
Feb 07, 2023―Uninformative Buy7.45K$3.32M
PCYC
Pharmacyclics
――――

You May Also Like

Markus Renschler insider profile FAQ

What stocks does Markus Renschler hold?
Markus Renschler holds: PCYC, CYT stocks.
What is Markus Renschler's role in Pharmacyclics?
Markus Renschler's role in Pharmacyclics is Sr. VP, Oncology Clinical Dev.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.